SKI Market

Indian Indices

Sensex

85,408.70 -116.14
( -0.14%)

Global Indices

Nasdaq

48,460.34 76.65
(0.16%)

Dow Jones

6,930.02 30.53
(0.44%)

Hang Seng

50,375.92 -36.95
(-0.07%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.61 0.03
(0.04%)

EUR-INR

105.18 0.31
(0.29%)

GBP-INR

120.34 0.55
(0.45%)

JPY-INR

0.57 0.00
(0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

32.9918134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

34.4

8292.9

EPS(TTM)

Face Value()

Div & Yield %

5.32

0.44

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1174.37	853.27	655.20	658.29	599.55	433.42
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1174.37	853.27	655.20	658.29	599.55	433.42
Other Income	69.83	62.07	60.48	42.25	31.16	0.17
Stock Adjustments	-0.70	7.25	10.19	-3.89	-0.55	5.63
Total Income	1243.50	922.59	725.87	696.65	630.16	439.22
EXPENDITURE :
Raw Materials	639.24	486.18	404.64	373.70	337.36	251.04
Power & Fuel Cost	30.73	26.04	14.24	11.49	10.90	8.68
Employee Cost	101.68	77.19	56.09	60.46	54.64	48.51
Other Manufacturing Expenses	64.62	46.10	21.09	5.25	6.98	4.76
Selling & Administrative Expenses	112.99	73.19	61.54	67.57	60.08	43.86
Miscellaneous Expenses	20.37	11.88	15.89	22.22	15.31	10.70
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	969.63	720.58	573.49	540.68	485.28	367.55
Operating Profit	273.88	202.01	152.38	155.97	144.87	71.66
Interest	1.17	0.99	3.61	3.80	5.35	7.29
Gross Profit	272.71	201.02	148.77	152.17	139.52	64.37
Depreciation	29.45	29.13	16.74	17.66	15.19	11.64
Profit Before Tax	243.26	171.89	132.03	134.51	124.33	52.73
Tax	52.14	37.46	29.34	30.02	28.19	11.15
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	2.84	0.68	-0.17	0.50	-2.24	3.68
Reported Net Profit	188.27	133.76	102.87	103.99	98.38	37.90
Extraordinary Items	0.51	0.07	-0.05	0.00	0.03	0.03
Adjusted Net Profit	187.76	133.69	102.92	103.99	98.35	37.87
Adjustment below Net Profit	-0.30	0.28	-8.64	0.05	-0.20	-0.39
P & L Balance brought forward	345.00	233.61	155.21	61.41	-32.69	-62.74
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	27.19	22.66	15.82	10.23	4.09	7.47
P & L Balance carried down	505.78	345.00	233.61	155.21	61.41	-32.69
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	80.00	60.00	50.00	25.00	25.00	10.00
Dividend Per Share(Rs)	0.80	0.60	0.50	0.25	0.25	0.10
Earnings Per Share-Unit Curr	4.15	2.95	2.27	2.54	2.40	0.93
Earnings Per Share(Adj)-Unit Curr	4.15	2.95	2.27	2.54	2.40	0.93
Book Value-Unit Curr	30.53	26.98	24.52	16.90	14.65	12.35
Book Value(Adj)-Unit Curr	30.53	26.98	24.52	16.90	14.65	12.35

85,408.70 -116.14 ( -0.14%)

48,460.34 76.65 (0.16%)

6,930.02 30.53 (0.44%)

50,375.92 -36.95 (-0.07%)

9,870.68 -18.54 (-0.19%)

89.61 0.03 (0.04%)

105.18 0.31 (0.29%)

120.34 0.55 (0.45%)

0.57 0.00 (0.36%)